[Therapy of dermatomyositis during childhood].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D011687:Purines / Q000037:antagonists & inhibitors; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D011687:Purines
Die Therapie der Dermatomyositis im Kindesalter.